Bloody Brilliant: The Next Chapter in Cancer Screening
<p>In the ever-evolving healthcare landscape, groundbreaking innovations often emerge to challenge the status quo.</p>
<p>I am a cancer doctor, and would love to see the disease caught earlier. Earlier detection typically translates into higher cure rates (with less intense treatment).</p>
<p>The recent approval by the U.S. Food and Drug Administration (FDA) for an <a href="https://pressroom.cancer.org/releases?item=1286#:~:text=WASHINGTON%2C%20DC%20%E2%80%93%20November%2020%2C,test%20to%20evaluate%20the%20technology%27s" rel="noopener ugc nofollow" target="_blank">investigational device study</a> of the <strong>Galleri test</strong> marks a significant milestone in cancer screening.</p>
<p>The Galleri blood test can potentially revolutionize how we detect cancer. The approach offers a non-invasive and comprehensive approach that could change the narrative of early diagnosis.</p>
<p><a href="https://medium.com/beingwell/bloody-brilliant-the-next-chapter-in-cancer-screening-8a1673e9f3e0"><strong>Learn More</strong></a></p>